Definitive radiotherapy for extracranial oligoprogressive metastatic renal cell carcinoma as a strategy to defer systemic therapy escalation-Reference-Cited by-同舟云学术

Definitive radiotherapy for extracranial oligoprogressive metastatic renal cell carcinoma as a strategy to defer systemic therapy escalation

Published:2021-07-23 Issue: Volume: Page:
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:BJU Int

Author:

De Brian¹^ORCID,Venkatesan Aradhana M.²,Msaouel Pavlos³⁴^ORCID,Ghia Amol J.¹,Li Jing¹,Yeboa Debra N.¹,Nguyen Quynh‐Nhu¹,Bishop Andrew J.¹,Jonasch Eric³,Shah Amishi Y.³,Campbell Matthew T.³,Wang Jennifer³,Zurita‐Saavedra Amado J.³,Karam Jose A.⁴⁵,Wood Christopher G.⁵^ORCID,Matin Surena F.⁵^ORCID,Tannir Nizar M.³,Tang Chad¹^ORCID

Affiliation:

1. Department of Radiation Oncology The University of Texas MD Anderson Cancer Center Houston TXUSA

2. Department of Abdominal Imaging Division of Diagnostic Imaging The University of Texas MD Anderson Cancer Center Houston TXUSA

3. Department of Genitourinary Medical Oncology Division of Cancer Medicine The University of Texas MD Anderson Cancer Center Houston TXUSA

4. Department of Translational Molecular Pathology Division of Pathology and Laboratory Medicine The University of Texas MD Anderson Cancer Center Houston TXUSA

5. Department of Urology Division of Surgery The University of Texas MD Anderson Cancer Center Houston TX USA

Publisher

Wiley

Subject

Urology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bju.15541

Reference52 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray F;CA Cancer J Clin,2018

2. The epidemiology of renal cell carcinoma;Ljungberg B;Eur Urol,2011

3. National Comprehensive Cancer Network (NCCN).NCCN Clinical Practice Guidelines in Oncology. Kidney Cancer 2020. Available at:https://www.nccn.org/guidelines/category_1. Accessed July 2021

4. Recent advancements in the treatment of metastatic clear cell renal cell carcinoma: A review of the evidence using second‐generation p‐values;Adashek JJ;Cancer Treat Res Commun,2020

5. Effect of switching systemic treatment after stereotactic radiosurgery for oligoprogressive, metastatic renal cell carcinoma;Barata PC;Clin Genitourinary Cancer,2018

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Definitive single fraction spine stereotactic radiosurgery for metastatic sarcoma: Simultaneous integrated boost is associated with high tumor control and low vertebral fracture risk;Radiotherapy and Oncology;2024-02

2. Navigating the ICI Combination Treatment Journey: Patterns of Response and Progression to First-Line ICI-Based Combination Treatment in Metastatic Renal Cell Carcinoma;Journal of Clinical Medicine;2024-01-05

3. The Diagnosis and Treatment Approach for Oligo-Recurrent and Oligo-Progressive Renal Cell Carcinoma;Cancers;2023-12-17

4. Role of Radiotherapy in Metastatic Renal Cell Carcinomas: An Evolutionary Journey in a Misunderstood Histological Type;Journal of Urologic Oncology;2023-11-30

5. Role of radiation in oligometastases and oligoprogression in metastatic non-small cell lung cancer: consensus and controversy;Expert Review of Respiratory Medicine;2023-11-02